By: Educate Inspire Change Research presented by Professor Nigel Bundred at the European Breast Cancer Conference in Amsterdam revealed that they had tested the effectiveness of a pair of drugs known as Herceptin (a.k.a trastuzumab) and Lapatinib. The two drugs are commonly used in breast cancer treatment already, but this is the first time they had…